---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-065493"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:12:56.233257+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Passage Bio announces 2023 annual meeting voting results

## Summary
- Elected three Class III directors: Athena Countouriotis (28.6M for), Saqib Islam (24.2M for), Sandip Kapadia (27.4M for).
- Ratified KPMG LLP as independent auditor for FY2023: 37.7M for, 279K against, 44K abstain; no broker non-votes.
- Approved amendment to certificate of incorporation for officer exculpation: 30.1M for, 1.5M against, 66.7K abstain, 6.2M broker non-votes.

## SEC filing metadata
- accession: 0001104659-23-065493
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/0001104659-23-065493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/tm2317140d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-065493
- JSON: https://secwatch.observer/filing/0001104659-23-065493.json
- Plain text: https://secwatch.observer/filing/0001104659-23-065493.txt

## Key facts
- Shareholder Votes
  Passage BIO, Inc. shareholders approved Election of three Class III directors at the 2023-05-25 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Election of three Class III directors, identified in the table below, each to serve a three-year term, which will expire at the 2026 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until their earlier resignation or removal: Nominees Shares For Shares Withheld Broker Non-Votes Athena Countouriotis, M.D. 28,649,239 3,089,674 6,239,108 Saqib Islam 24,225,087 7,513,826 6,239,108 Sandip Kapadia 27,401,976 4,336,937 6,239,108
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/0001104659-23-065493-index.htm
- Shareholder Votes
  Passage BIO, Inc. shareholders approved Approval of the amendment and restatement of the Company's amended and restated certificate of incorporation to permit the exculpation of the Company's officers from personal liability for certain breaches of the duty of care at the 2023-05-25 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Approval of the amendment and restatement of the Company’s amended and restated certificate of incorporation to permit the exculpation of the Company’s officers from personal liability for certain breaches of the duty of care : Shares For Shares Against Shares Abstaining Broker Non-Votes 30,135,810 1,536,404 66,699 6,239,108
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/0001104659-23-065493-index.htm
- Shareholder Votes
  Passage BIO, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-25 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-25
  source text: Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: Shares For Shares Against Shares Abstaining Broker Non-Votes 37,654,833 279,241 43,947 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/0001104659-23-065493-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.